Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06293807 · ClinicalTrials.gov registry record · Early Phase 1
Immediate Post-Operative Anesthesia With Either Lidocaine or Bupivacaine
A Early Phase 1 study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 72
- Enrollment target
NCT06293807: Completed Early Phase 1 study, sponsored by The University of Texas Health Science Center at San Antonio.
NCT06293807 is a Early Phase 1 study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 72 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (36% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06293807, a Early Phase 1 study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 72 participants
- Enrollment target
Study Summary
Immediate post-suturing administration of either one of two dental anesthetic solutions or a placebo prior to dismissal.
Primary Outcome
Pain response recorded using a 20 point visual Analog Scale. The VAS scale is a straight line scale scored from 0-20 with 0 indicating the least amount of pain and 20 the worst pain ever experienced.
Interventions
- OTHER Placebo
- DRUG Xylocaine 2 % with 1:100,000 epinephrine
- DRUG Bupivicaine 0.5% with 1:200,000 epinephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2022-06-06 |
| Est. Completion | 2023-04-16 |
| Phase | Early Phase 1 |
What the finished NCT06293807 record still lists
NCT06293807 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (36% higher).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT06293807 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06293807 about?
NCT06293807 is a clinical study titled "Immediate Post-Operative Anesthesia With Either Lidocaine or Bupivacaine". Immediate post-suturing administration of either one of two dental anesthetic solutions or a placebo prior to dismissal.
What is the current status of trial NCT06293807?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 72 participants. The study started on 2022-06-06. Estimated completion is 2023-04-16.
What interventions are being tested in trial NCT06293807?
The interventions under investigation include: Placebo (OTHER), Xylocaine 2 % with 1:100,000 epinephrine (DRUG), Bupivicaine 0.5% with 1:200,000 epinephrine (DRUG).
Who is sponsoring clinical trial NCT06293807?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06293807's enrollment target sits among peer trials
72 319th of 2000 higher than 1,674 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI